Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Donnez, 2002, The efficacy of medical and surgical treatment of endometriosis-associated infertility: Arguments in favour of a medico-surgical approach, Hum. Reprod. Update., 8, 89, 10.1093/humupd/8.1.89
Nisolle, 1997, Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities, Fertil. Steril., 68, 585, 10.1016/S0015-0282(97)00191-X
Ferrero, 2018, Current and emerging treatment options for endometriosis, Expert Opin. Pharmacother., 19, 1109, 10.1080/14656566.2018.1494154
Vercellini, 2016, Estrogen-progestins and progestins for the management of endometriosis, Fertil. Steril., 106, 1552, 10.1016/j.fertnstert.2016.10.022
Vercellini, 2018, Medical treatment of endometriosis-related pain, Best Pr. Res. Clin. Obstet. Gynaecol., 51, 68, 10.1016/j.bpobgyn.2018.01.015
Practice Committee of the American Society for Reproductive Medicine (2014). Treatment of pelvic pain associated with endome-triosis: A committee opinion. Fertil. Steril., 101, 927–935.
Dunselman, 2014, ESHRE guideline: Management of women with endometriosis, Hum. Reprod., 29, 400, 10.1093/humrep/det457
American College of Obstetricians and Gynecologists (2010). Management of endometriosis. ACOG practice bulletin no. 114. Obstet. Gynecol., 116, 223–236.
Leyland, 2010, Endometriosis: Diagnosis and management, J. Obstet. Gynecol. Can., 32, S1, 10.1016/S1701-2163(16)34589-3
Surrey, 2020, Real-World Characterization of Women with Diagnosed Endometriosis Initiating Therapy with Elagolix Using a US Claims Database, Clinicoecon Outcomes Res., 12, 473, 10.2147/CEOR.S264905
Soliman, 2017, The burden of endometriosis symptoms on health-related quality of life in women in the United States: A cross-sectional study, J. Psychosom. Obstet. Gynecol., 38, 238, 10.1080/0167482X.2017.1289512
Soliman, 2016, The direct and indirect costs associated with endometriosis: A systematic literature review, Hum. Reprod., 31, 712, 10.1093/humrep/dev335
Bulun, 2010, 17Beta-hydroxysteroid dehydrogenase-2 deficiency and progesterone resistance in endometriosis, Semin. Reprod. Med., 28, 44, 10.1055/s-0029-1242992
Yilmaz, 2019, Endometriosis and nuclear receptors, Hum. Reprod. Update, 25, 473, 10.1093/humupd/dmz005
Attia, 2000, Progesterone receptor isoform a but not b is expressed in endometriosis1, J. Clin. Endocrinol. Metab., 85, 2897
Bulun, 2006, Progesterone resistance in endometriosis: Link to failure to metabolize estradiol, Mol. Cell. Endocrinol., 248, 94, 10.1016/j.mce.2005.11.041
Han, 2015, Estrogen receptor b modulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis, Cell, 163, 960, 10.1016/j.cell.2015.10.034
Pavone, 2010, Altered retinoid uptake and action contributes to cell survival in endometriosis, J. Clin. Endocrinol. Metab., 95, E300, 10.1210/jc.2010-0459
Pavone, 2011, Endometriosis expresses a molecular pattern consistent with decreased retinoid uptake, metabolism and action, Hum. Reprod., 26, 2157, 10.1093/humrep/der172
Patel, 2017, Progesterone resistance in endometriosis: Origins, consequences and interventions, Acta Obstet. Gynecol. Scand., 96, 623, 10.1111/aogs.13156
Gargett, 2014, Potential role of endometrial stem/progenitor cells in the pathogenesis of early-onset endometriosis, Mol. Hum. Reprod., 20, 591, 10.1093/molehr/gau025
Ober, 1955, Observations on the endometrium and ovary in the newborn, Pediatrics, 16, 445, 10.1542/peds.16.4.445
Brosens, 2015, The endometrium from the neonate to the adolescent, J. Matern. Neonatal Med., 29, 1195, 10.3109/14767058.2015.1040756
Signorile, 2011, Embryologic origin of endometriosis: Analysis of 101 human female fetuses, J. Cell. Physiol., 227, 1653, 10.1002/jcp.22888
Donnez, 2002, Iron overload in the peritoneal cavity of women with pelvic endome-triosis, Fertil. Steril., 78, 712, 10.1016/S0015-0282(02)03346-0
Dolmans, 2002, Potential involvement of hemoglobin and heme in the pathogenesis of peritoneal endometriosis, Fertil. Steril., 77, 561, 10.1016/S0015-0282(01)03211-3
Lousse, 2012, Peritoneal endometriosis is an inflam-matory disease, Front. Biosci. Elite Ed., 4, 23, 10.2741/e358
Donnez, 2016, Oxidative stress in the pelvic cavity and its role in the pathogenesis of endometriosis, Fertil. Steril., 106, 1011, 10.1016/j.fertnstert.2016.07.1075
Agarwal, 2012, The effects of oxidative stress on female reproduction: A review, Reprod. Biol. Endocrinol., 10, 49, 10.1186/1477-7827-10-49
Lousse, 2009, Iron storage is significantly increased in peritoneal macrophages of endometriosis patients and correlates with iron overload in peritoneal fluid, Fertil. Steril., 91, 1668, 10.1016/j.fertnstert.2008.02.103
Patel, 2014, Role of nuclear progesterone receptor isoforms in uterine pathophysiology, Hum. Reprod. Updat., 21, 155, 10.1093/humupd/dmu056
Lousse, 2010, Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis, Fertil. Steril., 94, 1985, 10.1016/j.fertnstert.2010.01.013
Simpson, 2003, Genetics of endometriosis, Obstet. Gynecol. Clin. North Am., 30, 21, 10.1016/S0889-8545(02)00051-7
Koninckx, 2019, Pathogenesis of endometriosis: The genet-ic/epigenetic theory, Fertil. Steril., 111, 327, 10.1016/j.fertnstert.2018.10.013
Zubrzycka, A., Zubrzycki, M., Perdas, E., and Zubrzycka, M. (2020). Genetic, epigenetic, and steroidogenic modulation mechanisms in en-dometriosis. J. Clin. Med., 9.
Neal, 2020, Expression of stromal progesterone receptor and differential methylation patterns in the endometrium may correlate with response to progesterone therapy in endometrial complex atypical hyperplasia, Reprod. Sci., 27, 1778, 10.1007/s43032-020-00175-w
Wu, 2005, Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis, Am. J. Obstet. Gynecol., 193, 371, 10.1016/j.ajog.2005.01.034
Cakmak, 2010, Molecular mechanisms of treatment resistance in endometriosis: The role of progesterone–hox gene interactions, Semin. Reprod. Med., 28, 69, 10.1055/s-0029-1242996
Ding, 2010, Dioxin and endometrial progesterone resistance, Semin. Reprod. Med., 28, 59, 10.1055/s-0029-1242995
Heilier, 2008, Organochlorines and endometriosis: A mini-review, Chemosphere, 71, 203, 10.1016/j.chemosphere.2007.09.044
Heilier, 2004, Increased serum polychlorobiphenyl levels in Belgian women with adenomyotic nodules of the rectovaginal septum, Fertil. Steril., 81, 456, 10.1016/j.fertnstert.2003.07.011
Barragan, 2016, Human endometrial fibroblasts derived from mesenchymal progenitors inherit progesterone resistance and acquire an inflammatory phenotype in the endometrial niche in endometriosis, Biol. Reprod., 94, 118, 10.1095/biolreprod.115.136010
Canis, 1997, Revised American Society for Reproductive Medicine classification of endometriosis: 1996, Fertil. Steril., 67, 817, 10.1016/S0015-0282(97)81391-X
Donnez, 1996, Stereometric evaluation of peritoneal endometriosis and endometriotic nodules of the rectovaginal septum, Hum. Reprod., 11, 224, 10.1093/oxfordjournals.humrep.a019024
Donnez, 1996, Peritoneal endometriosis and “endometriotic” nodules of the rectovaginal septum are two different entities, Fertil. Steril., 66, 362, 10.1016/S0015-0282(16)58501-X
Donnez, 1998, Vascular endothelial growth factor (VEGF) in endometriosis, Hum. Reprod., 13, 1686, 10.1093/humrep/13.6.1686
Khan, 2004, Higher activity by opaque endometriotic lesions than nonopaque lesions, Acta Obstet. Gynecol. Scand., 83, 375, 10.1111/j.0001-6349.2004.00229.x
Hogg, 2020, Endometriosis-associated macrophages: Origin, phenotype, and function, Front. Endocrinol., 11, 7, 10.3389/fendo.2020.00007
Vercellini, 2017, Role of medical therapy in the management of deep rectovaginal endometriosis, Fertil. Steril., 108, 913, 10.1016/j.fertnstert.2017.08.038
Koninckx, 2012, Deep endometriosis: Definition, diagnosis, and treatment, Fertil. Steril., 98, 564, 10.1016/j.fertnstert.2012.07.1061
Donnez, O., and Donnez, J. (2020). Deep endometriosis: The place of laparoscopic shaving. Best Pr. Res. Clin. Obstet. Gynaecol.
Donnez, 1995, Surgery: Rectovaginal septum, endometriosis or adenomyosis: Laparoscopic management in a series of 231 patients, Hum. Reprod., 10, 630, 10.1093/oxfordjournals.humrep.a136001
Reis, 2020, Progesterone receptor ligands for the treatment of endometriosis: The mechanisms behind therapeutic success and failure, Hum. Reprod. Updat., 26, 565, 10.1093/humupd/dmaa009
Barra, 2019, A comprehensive review of hormonal and biological therapies for endometriosis: Latest developments, Expert Opin. Biol. Ther., 19, 343, 10.1080/14712598.2019.1581761
Flores, 2018, Progesterone receptor status predicts response to progestin therapy in endome-triosis, J. Clin. Endocrinol. Metab., 103, 4561, 10.1210/jc.2018-01227
Vercellini, 2018, Management of endometriosis: Toward value-based, cost-effective, affordable care, J. Obstet. Gynaecol. Can., 40, 726, 10.1016/j.jogc.2017.07.011
Vercellini, 2018, A stepped-care approach to symptomatic endometriosis management: A participatory research initiative, Fertil. Steril., 109, 1086, 10.1016/j.fertnstert.2018.01.037
Vercellini, 2017, Toward minimally disruptive management of symptomatic endometriosis: Reducing low-value care and the burden of treatment, Expert Rev. Pharmacoecon. Outcomes Res., 18, 1, 10.1080/14737167.2018.1411803
Vercellini, 2018, Are combined hormonal contraceptives the neglected treatment for symptomatic endometriosis?, Fertil. Steril., 110, 61, 10.1016/j.fertnstert.2018.03.038
Harada, 2008, Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: A placebo-controlled, double-blind, randomized trial, Fertil. Steril., 90, 1583, 10.1016/j.fertnstert.2007.08.051
Vinogradova, 2015, Use of combined oral contraceptives and risk of venous thromboembolism: Nested case-control studies using the QResearch and CPRD databases, BMJ, 350, h2135, 10.1136/bmj.h2135
Manzoli, 2012, Oral contraceptives and venous thromboembolism: A systematic review and meta-analysis, Drug Saf., 35, 191
Lidegaard, 2012, Venous thrombosis in users of non-oral hormonal contraception: Follow-up study, Denmark 2001–2010, BMJ, 344, e2990, 10.1136/bmj.e2990
Lidegaard, 2011, Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001–2009, BMJ, 343, d6423, 10.1136/bmj.d6423
Casper, 2017, Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills, Fertil. Steril., 107, 533, 10.1016/j.fertnstert.2017.01.003
Brion, F., Le Page, Y., Piccini, B., Cardoso, O., Tong, S.-K., Chung, B.-C., and Kah, O. (2012). Screening estrogenic activities of chemicals or mixtures in vivo using transgenic (cyp19a1b-gfp) zebrafish embryos. PLoS ONE, 7.
Speroff, 2000, The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol (femhrt??) on the frequency and intensity of vasomotor symptoms, Menopause, 7, 383, 10.1097/00042192-200011000-00003
Bernuit, 2011, Female perspectives on endometriosis: Findings from the uterine bleeding and pain women’s research study, J. Endometr., 3, 73, 10.5301/JE.2011.8525
Chapron, 2011, Oral contraceptives and endometriosis: The past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis, Hum. Reprod., 26, 2028, 10.1093/humrep/der156
Vercellini, 2011, Oral contraceptives and risk of endo-metriosis: A systematic review and meta-analysis, Hum. Reprod. Update, 17, 159, 10.1093/humupd/dmq042
Brown, 2014, Endometriosis: An overview of cochrane reviews, Cochrane Database Syst. Rev., 2014, CD009590
Jensen, 2018, Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: A systematic review of the evidence, Fertil. Steril., 110, 137, 10.1016/j.fertnstert.2018.03.012
Buggio, 2017, Oral and depot progestin therapy for endometriosis: Towards a personalisez medicine, Expert Opin. Pharmacother., 18, 1569, 10.1080/14656566.2017.1381086
Donnez, 1987, Combined (hormonal and microsurgical) therapy in infertile women with endometriosis, Fertil. Steril., 48, 239, 10.1016/S0015-0282(16)59349-2
Donnez, 1988, Histologic study of ovarian endometriosis after hormonal therapy, Fertil. Steril., 49, 423, 10.1016/S0015-0282(16)59766-0
Donnez, 1990, Evaluation of preoperative use of danazol, gestrinone, lynestrenol, buserelin spray and buserelin implant, in the treatment of endometriosis associated infertility, Prog. Clin. Boil. Res., 323, 427
Donnez, 1990, Endometriosis-associated infertility: Evaluation of preoperative use of danazol, gestrinone, and buserelin, Int. J. Fertil., 35, 297
Mabrouk, 2017, Short-term histopathological effects of dienogest therapy on ovarian endometriomas: In vivo, nonrandomized, controlled trial, Gynecol. Endocrinol., 34, 399, 10.1080/09513590.2017.1405932
Vercellini, 2016, Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: A before and after study, Fertil. Steril., 105, 734.e3, 10.1016/j.fertnstert.2015.11.016
Kim, 2013, Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer, Endocr. Rev., 34, 130, 10.1210/er.2012-1043
Donnez, 2017, Partial suppression of estradiol: A new strategy in endometriosis management?, Fertil. Steril., 107, 568, 10.1016/j.fertnstert.2017.01.013
Ferrero, 2012, Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies, Arch. Gynecol. Obstet., 287, 447, 10.1007/s00404-012-2581-2
Razzi, 2007, Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis, Eur. J. Obstet. Gynecol. Reprod. Biol., 135, 188, 10.1016/j.ejogrb.2006.08.002
Cursino, 2017, Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission, Eur. J. Obstet. Gynecol. Reprod. Biol., 211, 108, 10.1016/j.ejogrb.2017.02.015
Donnez, 2016, Uterine fibroid management: From the present to the future, Hum. Reprod. Update, 22, 665, 10.1093/humupd/dmw023
Donnez, 2020, Hormone therapy for intramural myoma-related infertility from ulipristal acetate to GnRH an-tagonist: A review, Reprod. Biomed. Online, 41, 431, 10.1016/j.rbmo.2020.05.017
Donnez, 2020, Fibroids and medical therapy: Bridging the gap from selective progesterone receptor modulators to gonadotropin-releasing hormone antagonist, Fertil. Steril., 114, 739, 10.1016/j.fertnstert.2020.07.028
Barbieri, 1992, Hormone treatment of endometriosis: The estrogen threshold hypothesis, Am. J. Obstet. Gynecol., 166, 740, 10.1016/0002-9378(92)91706-G
Chwalisz, 2012, The hormonal profile of norethindrone acetate: Rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis, Reprod. Sci., 19, 563, 10.1177/1933719112438061
(2020, October 01). European Society of Human Reproduction and Embryology ESHRE Guideline for the Diagnosis and Treatment of Endome-Triosis. Available online: http://guidelines.endometriosis.org/index.html.
Brown, 2010, Gonadotrophin-releasing hormone analogues for pain associated with endometriosis, Cochrane Database Syst. Rev., 2010, CD008475
Dragoman, 2016, Research gaps identified during the 2014 update of the WHO medical eligibility criteria for contraceptive use and selected practice recommendations for contraceptive use, Contracept, 94, 195, 10.1016/j.contraception.2015.12.009
Donnez, 2004, Surgical management of endometriosis, Best Pract. Res. Clin. Obstet. Gynaecol., 18, 329, 10.1016/j.bpobgyn.2004.03.004
Donnez, 1994, Advanced endoscopic techniques used in dysfunctional bleeding, fibroids and endometriosis, and the role of gonadotrophin-releasing hormone agonist treatment, Br. J. Obstet. Gynaecol., 101, 2, 10.1111/j.1471-0528.1994.tb13677.x
Ng, 2017, Dose-dependent suppression of gonadotropins and ovarian hormones by elagolix in healthy premenopausal women, J. Clin. Endocrinol. Metab., 102, 1683, 10.1210/jc.2016-3845
Carr, 2014, Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: Effects on bone mineral density, Reprod. Sci., 21, 1341, 10.1177/1933719114549848
Diamond, 2014, Elagolix treatment for endometriosis-associated pain: Results from a phase 2, randomized, double-blind, placebo-controlled study, Reprod. Sci., 21, 363, 10.1177/1933719113497292
Taylor, 2017, Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist, N. Engl. J. Med., 377, 28, 10.1056/NEJMoa1700089
Surrey, 2018, Long-term outcomes of elagolix in women with endometriosis: Results from two extension studies, Obstet. Gynecol., 132, 147, 10.1097/AOG.0000000000002675
Osuga, 2021, Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose-response manner: A randomized, double-blind, place-bo-controlled study, Fertil. Steril., 115, 397, 10.1016/j.fertnstert.2020.07.055
Donnez, 2020, Treatment of endome-triosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: A randomized clinical trial, Fertil. Steril., 114, 44, 10.1016/j.fertnstert.2020.02.114
Pohl, 2020, Effects of combined GnRH receptor antagonist linzagolix and hormonal add-back therapy on vaginal bleeding—Delayed add-back onset does not improve bleeding pattern, Reprod. Sci., 27, 988, 10.1007/s43032-020-00172-z
Taylor, 2019, Clinical evaluation of the oral gonadotropin-releasing hormone-antagonist elagolix for the management of endometriosis-associated pain, Pain Manag., 9, 497, 10.2217/pmt-2019-0010
Donnez, 2020, Gonadotropin-releasing hormone antagonist (linzagolix): A new therapy for uterine adenomyosis, Fertil. Steril., 114, 640, 10.1016/j.fertnstert.2020.04.017
Barra, 2019, Elagolix sodium for the treatment of women with moderate to severe endometriosis-associated pain, Drugs Today, 55, 237, 10.1358/dot.2019.55.4.2930713
Pokrzywinski, 2020, Achieving clinically meaningful response in endometriosis pain symptoms is associated with improvements in health-related quality of life and work productivity: Analysis of 2 phase III clinical trials, Am. J. Obstet. Gynecol., 222, 592.e1, 10.1016/j.ajog.2019.11.1255
Taylor, 2020, Health-related quality of life improvements in patients with endometriosis treated with elagolix, Obstet. Gynecol., 136, 501, 10.1097/AOG.0000000000003917
Taylor, 2019, Long term treatment of endometriosis associated pain (EAP) with linzagolix: Efficacy and safety after 12 months of treatment, Fertil. Steril., 112, e323, 10.1016/j.fertnstert.2019.07.935
Bestel, 2020, Quality of life results after 52 weeks of treatment with linzagolix for endometriosis-associated pain, Obstet. Gynecol., 135, 26S, 10.1097/01.AOG.0000663200.75027.38
Donnez, 2019, What if deep endometriotic nodules and uterine adenomyosis were actually two forms of the same disease?, Fertil. Steril., 111, 454, 10.1016/j.fertnstert.2018.12.018
Borini, 2020, Gonadotropin-releasing hormone antagonist linzagolix: Possible treatment for assisted reproduction patients presenting with adenomyosis and endometriosis?, Fertil. Steril., 114, 517, 10.1016/j.fertnstert.2020.06.003
Biberoglu, 1981, Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness, Am. J. Obstet. Gynecol., 139, 645, 10.1016/0002-9378(81)90478-6
Becker, 2020, Efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: Phase 3 randomized, double-blind, placebo-controlled study (spirit 2), Fertil. Steril., 114, e77, 10.1016/j.fertnstert.2020.08.238
Zandvliet, 2020, Simulated long-term effects of relugolix combination therapy on bone mineral density at the lumbar spine as predicted by a validated semi-mechanistic exposure-response model, Fertil. Steril., 114, e350, 10.1016/j.fertnstert.2020.08.1046
Practice Committee of the American Society for Reproductive Medicine (2018). American Society for Reproductive Medicine position statement on uterus transplantation: A committee opinion. Fertil. Steril., 110, 605–610.
Vercellini, 2019, Endometriosis Study, G. elagolix for endo-metriosis: All that glitters is not gold, Hum. Reprod., 34, 193, 10.1093/humrep/dey368
Donnez, 2017, Choosing the right surgical technique for deep endometriosis: Shaving, disc excision, or bowel resection?, Fertil. Steril., 108, 931, 10.1016/j.fertnstert.2017.09.006
Soliman, 2018, Real-world evaluation of direct and indirect economic burden among endometriosis patients in the United States, Adv. Ther., 35, 408, 10.1007/s12325-018-0667-3
Wang, 2019, Cost–effectiveness of elagolix versus leuprolide acetate for treating moderate-to-severe endometriosis pain in the USA, J. Comp. Eff. Res., 8, 337, 10.2217/cer-2018-0124
Leyland, N., Estes, S.J., Lessey, B.A., Advincula, A.P., and Taylor, H.S. (2020). A clinician’s guide to the treatment of endometriosis with elagolix. J. Womens Heal.